ERBITUX 500 MG

What is ERBITUX 500 MG?

ERBITUX 500 MG is a prescription medication containing Cetuximab 500 mg as its active ingredient. Cetuximab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of certain cancer cells.

---

What is the Use of ERBITUX 500 MG?

ERBITUX 500 MG is primarily used to:

• Treat EGFR-positive metastatic colorectal cancer.

• Manage head and neck squamous cell carcinoma.

• Be used in combination with chemotherapy or radiation therapy to slow tumor growth and improve treatment outcomes.

---

Benefits of ERBITUX 500 MG

• Helps inhibit cancer cell growth by targeting EGFR.

• Can be used with other treatments to enhance effectiveness.

• Offers a targeted therapy option for patients with EGFR-positive cancers.

---

Side Effects of ERBITUX 500 MG

Common side effects may include:

• Skin rash or acne-like eruptions

• Fatigue or weakness

• Fever or chills

• Nausea or vomiting

Serious but rare side effects may include:

• Severe infusion reactions (difficulty breathing, low blood pressure)

• Heart or lung complications

• Electrolyte imbalances

Patients should be closely monitored, especially during the first infusion, to manage any severe reactions.

1. What is ERBITUX 500 MG used for?

It is used to treat EGFR-positive metastatic colorectal cancer and head and neck squamous cell carcinoma.

2. What is the active ingredient in ERBITUX 500 MG?

The active ingredient is Cetuximab 500 mg, a monoclonal antibody targeting EGFR.

3. How does ERBITUX 500 MG work?

It binds to EGFR on cancer cells, blocking signals that promote tumor growth and spread.

4. How is ERBITUX 500 MG administered?

It is given as an intravenous infusion under the supervision of a healthcare professional.

5. Can ERBITUX 500 MG be used alone?

Yes, but it is often used with chemotherapy or radiation therapy for better treatment effectiveness.

6. What are common side effects?

Common side effects include skin rash, fatigue, fever, chills, nausea, or vomiting.

7. What are serious side effects?

Serious effects may include severe infusion reactions, heart or lung complications, or electrolyte imbalances. Immediate medical attention is required if these occur.

8. Who should avoid ERBITUX 500 MG?

Patients with allergies to Cetuximab, severe heart or lung issues, or previous severe infusion reactions should avoid this medication unless prescribed by a doctor.

9. Can it be used during pregnancy or breastfeeding?

Safety in pregnancy and breastfeeding is not established. Use only if the potential benefit outweighs the risk.

10. How often is ERBITUX 500 MG given?

Dosage and frequency depend on the type of cancer, body weight, and treatment protocol. Follow the oncologist’s instructions.

11. Can I take other medications while on ERBITUX 500 MG?

Inform your doctor about all medications and supplements, as some may interact with treatment.

12. How should ERBITUX 500 MG be stored?

Store in a refrigerator at 2–8°C, protected from light. Do not freeze.

13. What should I do if I experience a severe infusion reaction?

Stop the infusion immediately and notify medical staff. Emergency treatment may be required.

14. Does ERBITUX 500 MG cure cancer?

No. ERBITUX slows tumor growth and improves treatment outcomes, but it is not a definitive cure.

15. Is regular monitoring required during treatment?

Yes. Patients require regular blood tests, vital monitoring, and skin assessments to ensure safe and effective treatment.